NAAA
RMD icon

New Age Alpha Advisors’s ResMed RMD Stock Holding History

New Age Alpha Advisors’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$64.9K Buy
333
+110
+49% +$22.8K ﹤0.01% 876
2026
Q1 		$50.1K Sell
223
-4
-2% -$997 ﹤0.01% 725
2025
Q4 		$54.7K Sell
227
-483
-68% -$124K ﹤0.01% 710
2025
Q3 		$194K Hold
710
– – 0.01% 641
2025
Q2 		$183K Sell
710
-82
-10% -$19.6K 0.01% 646
2025
Q1 		$177K Sell
792
-9,213
-92% -$2.15M 0.01% 670
2024
Q4 		$2.29M Buy
+10,005
New +$2.41M 0.09% 297

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

New Age Alpha Advisors's RMD Position: Q2 2026 in Review

New Age Alpha Advisors increased its ResMed (RMD) stake by 49% in Q2 2026, buying an estimated $22.8K and bringing the position to 333 shares worth $64.9K. The position accounts for ﹤0.01% of the portfolio, ranked #876.

New Age Alpha Advisors first reported a position in RMD in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.29M in Q4 2024. 882 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • New Age Alpha Advisors held 333 shares of ResMed worth $64.9K as of Q2 2026.
  • New Age Alpha Advisors bought 110 ResMed shares in Q2 2026, an estimated $22.8K.
  • ResMed made up ﹤0.01% of New Age Alpha Advisors's portfolio in Q2 2026, its #876 holding.
  • New Age Alpha Advisors first reported a position in ResMed in Q4 2024 and has held it in 7 quarters since.
  • New Age Alpha Advisors's ResMed position peaked at $2.29M in Q4 2024.
  • 882 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on New Age Alpha Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.